into new lines of
business, including ClinPhone; the impact on the Company's business of
government regulation of the drug, medical device and biotechnology
industry; consolidation within the pharmaceutical industry and competition
within the biopharmaceutical services industry; the potential for
significant liability to clients and third parties; the potential adverse
impact of health care reform; and the effects of exchange rate fluctuations
and other international economic, political, and other risks. Such factors
and others are discussed more fully in the section entitled "Risk Factors"
of the Company's Annual Report on Form 10-K for the Fiscal Year ended June
30, 2008 as filed with the SEC on August 28, 2008, which "Risk Factors"
discussion is incorporated by reference in this press release. The
forward-looking statements included in this press release represent the
Company's estimates as of the date of this release. The Company
specifically disclaims any obligation to update these forward-looking
statements in the future. These forward-looking statements should not be
relied upon as representing the Company's estimates or views as of any date
subsequent to the date of this press release.
PAREXEL is a registered trademark of PAREXEL International Corporation,
and Perceptive Informatics is a trademark of Perceptive Informatics, Inc.
All other names or marks may be registered trademarks or trademarks of
PAREXEL International Corporation, Perceptive Informatics, Inc. or their
respective owners and are hereby acknowledged.
Jennifer Baird Rebecca Passo
Senior Director of Public Relations SHIFT Communications
PAREXEL International Tel: +617-681-1217
Tel: +781-434-4409 Email: firstname.lastname@example.org
Email: Jennifer.Baird@PAREXEL.comPage: 1 2 3 4 5 6 Related biology technology :1
. Perceptive Informatics Enhances Medical Imaging Capabilities for Assessment of Cardiac Function2
. Perceptive Informatics Improves Clinical Site Monitoring Access and Flexibility With Portable USB Drive Capability3
. White Paper Examines New Thin LIMS IT Implementation Strategy for cGMP Quality Informatics4
. DNA2.0 Launches New Website: Enhanced Design and Free Bioinformatics Tools Demonstrate DNA2.0's Customer Focus 5
. BioInformatics, LLC Offers Solutions for Optimizing Service and/or Maintenance Contracts6
. Sigma-Aldrich Recognized by BioInformatics, LLC as Having the Most Useful and Easiest to Use Online and Print Catalogs7
. NorthPoint Domain and NYU Vascular Associates Partner to Develop New Generation of Care Delivery Informatics Instruments8
. Core Informatics Delivers Enterprise Core LIMS Installation to BioRelix Pharmaceuticals9
. IC Sciences Launches ICS Alliance to Advance Development and Adoption of Informatics Instruments for Next Generation Healthcare10
. Core Informatics Completes Successful LIMS Implementation for Progenics Pharmaceuticals11
. BioInformatics, LLC Studies Trade Show Exhibition Strategies in the Life Science Market